Background Severe hypertension increases the mother’s risk of heart attack, cardiac failure, cerebral vascular accidents and renal failure. Numerous candidate biomarkers have been proposed for prediction of disease, including placental hormones, angiogenic factors, and lipids. To date, none of them, nor any combination has emerged with requisite specificity and sensitivity to be of clinical uses. Objectives To compare pregnancy outcomes between patients with elevated uric acid (≥6mg/dl) levels and normal levels (<6mg/dl). Method This was a case- control study which was conducted on 104 pregnant women who were in their second half of pregnancy. The women were recruited from the antenatal clinic of the Jos University Teaching Hospital from the period of March 2019 to December 2019 and were divided into two groups using the nonprobability sampling technique. Systolic and diastolic blood pressure was measured and recorded on a prefixed questionnaire (blood pressure of at least 140/90mmHg was taken as a cut-off for inclusion into the study). The blood pressure was measured using the mercury sphygmomanometer; and the mean of two readings taken. Five mls of blood was collected from the ante cubital fossa vein under aseptic condition and a second sample was taken at the time of delivery from 52 normotensives and 52 hypertensive women and matched for gestational age to assay for uric acid levels. Outcome variables assessed was the gestational age at delivery, need for intervention, preterm birth, birth weight, APGAR, Perinatal death and SCBU admission